GGrantIndex
← Search

EXTENSION OF PARALLELAVAX TECHNOLOGY TO HUMAN VACCINE TESTING

$850,018FY2008Department of the ArmyDOD

Maxygen, Inc., Redwood City CA

Investigators

View source on USAspending →